Gene: SENP7
Official Full Name: SUMO specific peptidase 7provided by HGNC
Gene Summary: The reversible posttranslational modification of proteins by the addition of small ubiquitin-like SUMO proteins (see SUMO1; MIM 601912) is required for many cellular processes. SUMO-specific proteases, such as SENP7, process SUMO precursors to generate a C-terminal diglycine motif required for the conjugation reaction. They also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]).[supplied by OMIM, Jun 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01447 | SENP7 Knockout cell line(SK-BR-3) | Human | SENP7 | 1:2~1:3 | Negative | Online Inquiry |
KO14217 | SENP7 Knockout cell line (HeLa) | Human | SENP7 | 1:3~1:6 | Negative | Online Inquiry |
KO14218 | SENP7 Knockout cell line (HCT 116) | Human | SENP7 | 1:2~1:4 | Negative | Online Inquiry |
KO14219 | SENP7 Knockout cell line (HEK293) | Human | SENP7 | 1:3~1:6 | Negative | Online Inquiry |
KO14220 | SENP7 Knockout cell line (A549) | Human | SENP7 | 1:3~1:4 | Negative | Online Inquiry |
SENP7 Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the SENP7 gene, which encodes a member of the SUMO-specific protease family involved in the post-translational modification of proteins. This genetic alteration allows researchers to study the physiological and pathological roles of SENP7 in various biological contexts. The knockout of the SENP7 gene enables the investigation of its impact on cellular processes such as stress response, apoptosis, and cell cycle regulation, as well as its implications in diseases where SUMOylation plays a critical role.
The principal function of SENP7 is to regulate the sumoylation of target proteins, which affects their stability, localization, and activity. By deleting the SENP7 gene, these cell lines facilitate a deeper understanding of the consequences of disrupted sumoylation pathways, thereby revealing potential molecular mechanisms underlying certain diseases, including cancer and neurodegenerative disorders. Such investigations are critical for identifying new therapeutic targets and developing innovative treatment strategies.
In comparison to conventional cell lines, SENP7 Gene Knockout Cell Lines offer significant advantages, including precise genetic modifications that allow for the direct observation of the SENP7 protein's physiological roles. These unique features make them invaluable resources for academic researchers and pharmaceutical companies alike. They streamline the experimental process by providing a clearer interpretation of experimental outcomes without the confounding effects of SENP7 activity.
Researchers, clinicians, and biotechnologists can leverage SENP7 Gene Knockout Cell Lines to design impactful experiments that advance our understanding of cellular mechanisms and disease pathology. The ability to analyze the specific contributions of SENP7 opens doors to targeted research initiatives and translational projects in therapeutics.
Our company specializes in providing high-quality biological products and models, underpinned by extensive expertise in genetic engineering and cellular biology. We are committed to supporting the scientific community with innovative tools that accelerate research and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.